Latest News About - Haematology and pathology devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Tuesday, February 20, 2018

10:56:00 AM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
lb
lo
lt
lv
mk
ml
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Vic Gundotra said: "This recognition of AliveCor as the leader in artificial intelligence validates our leadership in the collection and analysis of patient generated data to help patients and providers assess and manage heart conditions more conveniently, more quickly, and less expensively than ever before," External link

prnewswire Tuesday, February 20, 2018 6:32:00 AM CET

Jon Medved said: “The winds were blowing in from the east at the summit, both in terms of investor base as well as market focus for start-ups,” External link

bloomberg Monday, February 19, 2018 2:23:00 PM CET

Anne Schuchat said: “You think about how bad it was in 1918, and you think surely our modern medical technology will save us, but influenza is the Hollywood movie writer’s worst nightmare,” External link

aawsat Monday, February 19, 2018 2:02:00 PM CET

John M Barry said: “Obviously, we still have no control over the virus,” External link

aawsat Monday, February 19, 2018 2:02:00 PM CET

Anthony S Fauci warned: “One hundred years after the lethal 1918 flu we are still vulnerable,” External link

aawsat Monday, February 19, 2018 2:02:00 PM CET

Henrik Zetterberg says: “The data aren't as conclusive as we would have hoped, so I was surprised by the rapid FDA approval,” External link

scientificamerican Sunday, February 18, 2018 4:23:00 PM CET

Henrik Zetterberg says: “It's promising that the FDA has approved something,” External link

scientificamerican Sunday, February 18, 2018 4:23:00 PM CET

Gregg Fonarow said: "The present environment for heart failure is substantially improved, and the future holds promises that will truly remove the term 'failure' from the description of this illness," External link

medicinenet Sunday, February 18, 2018 7:48:00 AM CET

Clyde Yancy said: "Anybody in the population over the age of 40 has a 20 percent chance of developing heart failure, regardless of your medical history," "Which means, in short, that all of us are at risk. And of course those with a history of have an even higher risk" External link

medicinenet Sunday, February 18, 2018 7:48:00 AM CET

Gregg Fonarow noted: "Even for the patient with far advanced disease, the utility of mechanical support -- artificial heart pumping devices -- has become remarkable," "We can sustain patients for a time sufficiently long enough to not only allow for heart transplantation, but also to serve as definitive therapy and, even more provocatively, to support recovery of heart muscle function" External link

medicinenet Sunday, February 18, 2018 7:48:00 AM CET

Clyde Yancy noted: "It is a reality that will take some more time to be fully realized," "But it is assuredly coming down the road" External link

medicinenet Sunday, February 18, 2018 7:48:00 AM CET

Clyde Yancy noted: "For many people, heart failure is a fuzzy disease," "People commonly think about their risk for a dramatic event, like a heart attack. But heart failure needs to be on everyone's consciousness because it develops quietly over time, as the heart gets weighed down by burdens such as , diabetes and ," External link

medicinenet Sunday, February 18, 2018 7:48:00 AM CET

Clyde Yancy said: "So, it's important to galvanize the public so that everyone knows that heart failure can be treated, but also prevented," "Because even though we can't cure it, we do know how to handle it. So, we can't approach it as if it's an inevitability. Because it's not" External link

medicinenet Sunday, February 18, 2018 7:48:00 AM CET

Joan Taylor explained: "The gel material contains a lock-and-key chemical interaction that holds the gel together and this is interrupted by the presence of glucose that enters the device gel layer from the fluid surrounding it in the body. When the gel softens, the insulin in it travels much more quickly and reaches the body circulation. Once the insulin has lowered the blood glucose , glucose starts to leave the gel again and the gel hardens, effectively closing the gateway," External link

medicinenet Sunday, February 18, 2018 7:18:00 AM CET

Joan Taylor said: "If [the gel] did not re-harden, the dose released would be higher than it should be," External link

medicinenet Sunday, February 18, 2018 7:18:00 AM CET

Joan Taylor said: "It goes without saying that the medical engineering needs to be perfect. It must not leak or be vulnerable to easy damage. We absolutely recognize that insulin is an extremely potent drug that needs respect," External link

medicinenet Sunday, February 18, 2018 7:18:00 AM CET

Yisrael Katz recalled: "Some of them had symptoms that lasted one, two and three days, but they neglected them and said, 'it is not strong enough; let us wait,' " "Then I started to read the statistics about how many people in the world die from a heart attack before getting medical aid, and I was shocked. Something had to be done" External link

waltainfo Friday, February 16, 2018 12:56:00 PM CET

Steven Nissen said: "The regulatory pathway for approval of such a device in the United States is daunting," "When you're dealing with a life-threatening disorder, [a product developer] would need to invest an enormous amount of money in proving it was safe and effective, especially for home use" External link

waltainfo Friday, February 16, 2018 12:56:00 PM CET

Yisrael Katz insisted: "It will be $10 to $20 per test," "Not big money for your health" External link

waltainfo Friday, February 16, 2018 12:56:00 PM CET

Ulf Wiinberg states: “We are pleased to receive orphan designation for IdeS in the US for the treatment of Guillain-Barré syndrome. IdeS’ fast and effective ability to cleave IgG antibodies has significant treatment potential in Guillain-Barré syndrome and we are planning a Phase II study with IdeS in this acute neurological disease” External link

realtid Friday, February 16, 2018 11:02:00 AM CET

Carlos Pena said: “Time is critical following the onset of stroke symptoms. Expanding the treatment window from 6 to 24 hours will significantly increase the number of stroke patients who may benefit from treatment,” External link

fda Thursday, February 15, 2018 6:49:00 PM CET

Jeffrey Shuren said: “A blood test to aid in concussion evaluation is an important tool for the American public and for our service members abroad, who need access to quick and accurate tests,” External link

nytimes Thursday, February 15, 2018 1:03:00 AM CET

Richard Pazdur said: “The FDA evaluates a variety of methods that measure a drug’s effect, called endpoints, in the approval of oncology drugs. This approval is the first to use the endpoint of metastasis-free survival, measuring the length of time that tumors did not spread to other parts of the body or that death occurred after starting treatment,” External link

fda Wednesday, February 14, 2018 8:14:00 PM CET

Jeffrey Shuren said: "A blood test to aid in concussion evaluation is an important tool for the American public and for our service members abroad who need access to quick and accurate tests," External link

prnewswire Wednesday, February 14, 2018 7:53:00 PM CET

Jeffrey Shuren said: “A blood test to aid in concussion evaluation is an important tool for the American public and for our Service Members abroad who need access to quick and accurate tests,” External link

fda Wednesday, February 14, 2018 7:44:00 PM CET

Robert Battista stated: "These recommendations are important for physicians' knowledge and clinical management to guide the appropriate use of these new immunotherapeutics," External link

prnewswire Wednesday, February 14, 2018 6:57:00 PM CET

Anita Tollstadius säger: - ContextVision, världsledande leverantör av mjukvaror för medicinsk bildbehandling och specialister inom artificiell intelligens, har utökat sin grupp av rådgivare (Advisory Board) för DESUTO, ett Eurostar sponsrat forskningsprogram inom digital patologi. Professor Junya Fukuoka från Department of Pathology i Nagasaki och Professor Fredrik Pontén från Uppsala University har båda anslutit sig till denna grupp av framträdande experter. Fukuoka är specialist inom lungcancer och har skapat the Nagasaki NET, ett nätverk för digital patologi, och är djup involverad i specialistutbildning av patologer i Japan. Pontén är certifierad specialist inom anatomisk patologi, expert inom hudcancer och medicinsk chef för Human Protein Atlas projektet. DESUTO Advisory Board omfattar nu experter in om en mängd olika discipliner: · Prof. Anil Parwani, prostatacancer expert. · Dr. Jeroen van der Laak, expert på deep learning-baserad analys av patologibilder. · Dr. Dan Ciresan, pionjär inom deep learning-teknologin. · Prof. Junya Fukuoka, expert inom lungsjukdomar. · Prof. Fredrik Pontén, hudcancerexpert. "Vi är väldigt glada över att ha etablerat ett Advisory Board med en sådan bredd av expertis och kompetens. Det är av oerhört stor vikt för att vi skall kunna utveckla produkter som tillför riktigt stort värde", External link

euroinvestor Wednesday, November 8, 2017 5:02:00 PM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.